1. Fisher NDL, Curfman G. Hypertension-A Public Health Challenge of Global Proportions[J]. JAMA,2018,17,1757-9.
2.Wang Z, Chen Z, Zhang L, Wang X, Hao G , Zhang Z, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012- 2015 [J]. Circulation. 2018,137(22):2344-56.
3. Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J, et al. Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses[J]. Hypertens Res. 2019,42(2):273-83.
4.Chen J, Zhang C, Wu Y, Zhang D. Association between Hypertension and the Risk of Parkinson's Disease: A Meta-Analysis of Analytical Studies [J]. Neuroepidemiology. 2019,52(3-4):181-92.
5. He J, Klag MJ, Wu Z, Whelton PK.Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke[J]. Stroke. 1995,26(12):2228-32
6. Han H, Guo W, Shi W, Yu Y, Zhang Y, Ye X, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis[J]. Sci Rep. 2017,7:44877.
7. G Yang, Y Wang, Y Zeng, et al. Rapid health transition in China, 1990–2010: findings from the global burden of disease study 2010[J]. Lancet 2013, 381: 1987- 2015.
8. Ferrannini E, Cushman WC. Diabetes and hypertension: the bad companions[J]. Lancet, 2012, 380: 601-10.
9. Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A View Beyond HbA1c: Role of Continuous Glucose Monitoring[J]. Diabetes Ther. 2019 10(3): 853-63
10. Boursier G, Sultan A, Molinari N, Maimoun L, Boegner C, Picandet M, et al. Triglycerides and glycated hemoglobin for screening insulin resistance in obese patients[J]. Clin Biochem. 2018,53:8-12.
11. Seino Y, Nanjo K, Tajima N, et al. Report of Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus[J]. J Diabetes Investig. 2010,1:(5)212-28.
12. Matsushita K, Blecker S, Pazin-Filho A, et al. The association of hemoglobin a1c with incident heart failure among people without diabetes: The atherosclerosis risk in communities study[J]. Diabetes. 2010;59(8):2020-6.
13. Cavero-Redondo I, Peleteiro B, Alvarez-Bueno C, Rodriguez-Artalejo F, Martinez -Vizcaíno V. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis[J]. BMJ Open. 2017,7(7):e015949
14. Kang SH, Jung DJ, Choi EW, Cho KH, Park JW, Do JY. HbA1c Levels Are Associated with Chronic Kidney Disease in a Non-Diabetic Adult Population: A Nationwide Survey (KNHANES 2011–2013) [J]. PLoS One. 2015,10(12):e0145827.
15. Scicali R, Giral P, Gallo A, Di Pino A, Rabuazzo AM, Purrello F,et al. HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients[J]. Atherosclerosis. 2016,255:102-8.
16. Nishiyama M, Kimijima M, Muto T, Kimura K.Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders[J]. Environ Health Prev Med. 2012,17(4):285-91.
17. Li AL, Peng Q, Shao YQ, Fang X, Zhang YY.The effect of body mass index and its interaction with family history on hypertension: a case-control study[J]. Clin Hypertens. 2019,25:6
18. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med. 1998,15:539-53.
19. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension[J]. Chine J Cardiology 2011,39:579-616.
20. Chen C, Lu FC,Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults[J].Biomed EnvironSci. 2004,17 Suppl:1-36.
21. Chu JR, Gao JL, Zhao SP, et al. Blood Lipid Abnormity Prevention Guidance in Chinese Adult [J]. Chinese Circulation Journal, 2016, 31 (10):937-953
22.Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction [J]. Eur J Epidemiol. 2005, 20:575-9.
23.Knol MJ, VanderWeele TJ, Groenwold RH, et al. Estimating measures of interaction on an additive scale for preventive exposures [J]. Eur J Epidemiol. 2011, 26 (6): 433-38.
24. Prasad K. Does HbA1cc Play a Role in the Development of Cardiovascular Diseases? [J] Curr Pharm Des. 2018,24(24):2876-82.
25. Metcalf PA, Kyle C, Kenealy T, Jackson RT. HbA1c in relation to incident diabetes and diabetes-related complications in non-diabetic adults at baseline[J]. J Diabetes Complications. 2017,31(5):814-23.
26. Arbel Y, Zlotnik M, Halkin A, Havakuk O, Berliner S, Herz I, et al. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non- diabetic patients undergoing coronary angiography[J]. Clin Res Cardiol. 2014, 103(3): 223-7.
27.Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis[J]. Clin Chim Acta. 2017, 464:57-63.
28. Jung CH, Rhee EJ, Kim KJ, Kim BY, Park SE, Chang Y, et al. Relationship of glycated hemoglobin A1c, coronary artery calcification and insulin resistance in maleswithout diabetes[J]. Arch Med Res. 2015,46(1):71-7.
29. Boursier G, Sultan A, Molinari N, Maimoun L, Boegner C, Picandet M, et al. Triglycerides and glycated hemoglobin for screening insulin resistance in obese
patients [J]. Clin Biochem. 2018,53:8-12.
30. Saisho Y.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease? [J] Int J Mol Sci. 2014,15(10):18381-406.
31. Chen Y, Huang Y, Li X, Xu M, Bi Y, Zhang Y, et al. Association of arterial stiffness with HbA1c in 1,000 type 2 diabetic patients with or without hypertension[J]. Endocrine. 2009,36(2):262-7.
32. Zeng Q, Dong SY, Wang ML, Wang WM, Li JM, Dai ZX, et al.Serum glycated albumin, glycated hemoglobin, and arterial stiffness in a general Chinese population [J] . Clin Chim Acta. 2017,468:33-8.
33. Chugh SN, Dabla S, Jain V, Chugh K, Sen J. Evaluation of endothelial function and effect of glycemic control (excellent vs. poor/ fair control) on endothelial function in uncontrolled type 2 diabetes mellitus[J]. J Assoc Physicians India. 2010,58:478-80.
34. Griffin TP , Wall D , Browne GA, Dennedy MC , O'Shea PM. Associations between glycaemic control and activation of the Renin Angiotensin Aldosterone System in participants with Type 2 Diabetes Mellitus and Hypertension[J]. Ann Clin Biochem. 2018,55(3):373-84.
35. Dizdarevic-Bostandzic A, Begovic E, Burekovic A, Velija-Asimi Z, Godinjak A, Karlovic V. Cardiovascular Risk Factors in Patients with Poorly Controlled Diabetes Mellitus[J]. Med Arch. 2018,72(1):13-16.
36. Bower JK, Appel LJ, Matsushita K, Young JH, Alonso A, Brancati FL, Selvin E.
Glycated Hemoglobin and Risk of Hypertension in the Atherosclerosis Risk in Communities Study[J]. Diabetes Care. 2012,35(5):1031-7.
37. Britton KA, Pradhan AD, Gaziano JM, Manson JE, Ridker PM, Buring JE, Sesso HD. Hemoglobin A1c, Body Mass Index, and the Risk of Hypertension in Women[J]. Am J Hypertens. 2011,24(3):328-34.
38.Hidru TH, Yang X, Xia Y, Ma L, Li HH.
The relationship between Plasma Markers and Essential Hypertension in Middle-aged and Elderly Chinese Population: A Community Based Cross-sectional Study[J]. Sci Rep. 2019,9(1):6813.
39. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of
HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study[J]. Diabetes. 1992,41(2):202-8.
40. Au Yeung SL, Luo S, Schooling CM. The impact of glycated hemoglobin on risk of hypertension: a Mendelian randomization study using UK Biobank[J]. J Hypertens. 2019 Aug 1.
41. Heianza Y , Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, et al.Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: Toranomon hospital health management center study 16(TOPICS 16) [J]. J Hum Hypertens. 2015,29(4):254-9.
42. Geva M , Shlomai G, Berkovich A , Maor E , Leibowitz A , Tenenbaum A , et al. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension[J]. Cardiovasc Diabetol. 2019,18(1):53.
43. Kroke A, Liese AD, Keil U, Boeing H. Arterial hypertension and glycemia in non-diabetic subjects: is there an association independent of obesity[J]? Diabetes Metab Res Rev. 1999,15(2):99-105.
44. Jiang SZ, Lu W, Zong XF, Ruan HY, Liu Y. Obesity and hypertension[J]. Exp Ther Med. 2016,12(4):2395-2399.
45. Janghorbani M, Aminorroaya A, Amini M.Comparison of Different Obesity Indices for Predicting Incident Hypertension[J]. High Blood Press Cardiovasc Prev. 2017, 24(2):157-166.
46. Guzik TJ, Mangalat D, Korbut R. Adipocytokines -novel link between inflammation and vascular function[J]? J Physiol Pharmacol. 2006,57(4):505-28.